33 results
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
1,292 8,799 R&D (30,671) (27,388) (3,283) G&A (18,177) (9,284) (8,893) Loss on disposal of property and equipment - (3,768) 3,768 Total operating expense
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
salaries and related costs, clinical trial costs related to obe-cel, and a decrease in our U.K. reimbursable R&D tax credits claimable through the U.K
8-K
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
Officer at Oxford Biomedica, a contract development and manufacturing organization. He previously served as Head of R&D at Swedish Orphan Biovitrum and also
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, as under such program the trading losses that arise from our qualifying R&D activities can be surrendered for a cash rebate of up to 33.35% of qualifying … to the SME regime on March 4, 2024 which include the introduction of a new rate for R&D intensive companies of 27% (which we may qualify for) and comes
8-K/A
EX-99.1
ticdh pb494t7ansmupq
15 Mar 24
Results of Operations and Financial Condition
4:21pm
8-K
EX-99.1
9nwc jkiexg
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.2
brkf7jo2 80g
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
ak31ldwzagsezwb q2e
13 Feb 24
Regulation FD Disclosure
4:06pm
8-K
EX-99.2
vno1prj56a8b skls
11 Dec 23
Regulation FD Disclosure
8:31am
10-Q
zx5 zlxz8c
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
2s7 flx8ccmqvq
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
al0v9flt5486 dmq52a
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
l9h u3p307sa
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
424B5
wyk6ne80wensr7srxb
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
jyzxh 2xquke
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
p7a17gduo
1 Jul 22
Current report (foreign)
5:15pm
6-K
EX-99.2
kdzuj72ns qr3vr
3 Nov 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.2
4wi4gwj0tgthvcqj
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm